°í°üÀý ¼ö¼ú ȯÀÚ¿¡¼ Á¤¸ÆÇ÷Àü»öÀüÁõÀÇ ¿¹¹æ
Prevention of Venous Thromboembolism in Hip Surgery Patients
Hip & Pelvis 2014³â 26±Ç 1È£ p.1 ~ p.6
¹ÚÀ±¼ö(Park Youn-Soo) - ¼º±Õ°ü´ëÇб³ Àǰú´ëÇÐ »ï¼º¼¿ïº´¿ø Á¤Çü¿Ü°úÇб³½Ç
ÀÓ½ÂÀç(Lim Seung-Jae) - ¼º±Õ°ü´ëÇб³ Àǰú´ëÇÐ »ï¼º¼¿ïº´¿ø Á¤Çü¿Ü°úÇб³½Ç
ÀÌÅÂÈÆ(Lee Tae-Hun) - ¼º±Õ°ü´ëÇб³ Àǰú´ëÇÐ »ï¼º¼¿ïº´¿ø Á¤Çü¿Ü°úÇб³½Ç
Abstract
Àΰø °í°üÀý Àüġȯ¼úÀ̳ª °í°üÀý °ñÀý ¼ö¼ú ÈÄ¿¡ Á¤¸ÆÇ÷»öÀüÁõ ¹ß»ý À§Ç輺Àº ´Ù¸¥ ¾î¶² ¼ö¼úº¸´Ù ³ô°Ô º¸°íµÇ°í ÀÖ´Ù. ÀÌ·¯ÇÑ Áõ»óÀÌ ÀÖ´Â ½ÉºÎÁ¤¸ÆÇ÷ÀüÁõÀ̳ª Æó»öÀüÁõÀÇ ¹ß»ý À§Ç輺 ¶§¹®¿¡ °í°üÀý ¼ö¼ú ȯÀÚ¿¡¼´Â Á¤¸ÆÇ÷»öÀüÁõ ¿¹¹æ¿ä¹ýÀÌ ÇÊ¿äÇÑ °ÍÀ¸·Î ÀϹÝÀûÀ¸·Î ¹Þ¾Æµé¿©Áö°í ÀÖ´Ù. Á¤¸Æ»öÀü Ç÷ÀüÁõÀÇ ¿¹¹æÀ» À§ÇØ »ç¿ëµÇ´Â ÀûÀýÇÑ ¹æ¹ýÀ¸·Î´Â ¹°¸®Àû ¿ä¹ý°ú ¾à¹° ¿ä¹ýÀÌ Àִµ¥, ¾ÆÁ÷±îÁö ÀÌ»óÀûÀÎ ´ÜÀÏ¿ä¹ýÀ¸·Î ¹àÇôÁø °ÍÀº ¾ø´Ù. Á¤¸Æ»öÀüÇ÷ÀüÁõÀÇ ¿¹¹æ¿ä¹ýÀ» ¼±ÅÃÇÒ ¶§´Â ±× È¿°ú¿Í ¾ÈÁ¤¼º¿¡ ´ëÇÑ ±ÕÇüÀ» °¡Áö°í ÅÃÇÏ¿©¾ß ÇÑ´Ù. º» ³í¹®¿¡¼´Â °í°üÀý ¼ö¼ú ȯÀÚ¿¡¼ Á¤¸ÆÇ÷»öÀüÁõ ¿¹¹æ¿ä¹ýÀ¸·Î ÇöÀç »ç¿ëµÇ°í ÀÖ´Â ´Ù¾çÇÑ ¹æ¹ýµé¿¡ ´ëÇÏ¿© ³íÇϰíÀÚ ÇÑ´Ù.
The risk for venous thromboembolism (VTE) in total hip arthroplasty and hip fracture surgery is much higher than that of any other surgery. There is a general agreement that prevention of VTE in hip surgery patients is necessary due to concerns regarding symptomatic deep vein thrombosis or fatal pulmonary embolism. Optimal strategies for prevention of VTE include pharmacologic and mechanical approaches; however, the ideal prophylactic regimen has not been identified. Selection of a prophylactic regimen should be balanced between efficacy and safety. This article discusses the different prophylactic options available today for prevention of VTE in hip surgery patients.
Ű¿öµå
°í°üÀý ¼ö¼ú, Á¤¸ÆÇ÷Àü»öÀüÁõ, ¿¹¹æ
Hip surgery, Venous thromboembolism, Prevention
KMID :
1028220140260010001
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)